Financial Statements — ALMS
Balance Sheet
(in billions USD)| Metric | Q2
2026 | Q1
2026 | Q3
2025 | Q2
2025 | Q1
2025 | Q3
2024 | Q2
2024 |
|---|
| Cash & Equivalents | 0.06 | 0.06 | 0.07 | 0.15 | 0.13 | 0.21 | 0.16 |
| Short-term Investments | -- | -- | 0.31 | 0.33 | 0.08 | 0.15 | 0.05 |
| Total Current Assets | 0.51 | 0.53 | 0.39 | 0.52 | 0.23 | 0.38 | 0.22 |
| Property, Plant & Equipment | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| Total Non-current Assets* | 0.05 | 0.14 | 0.09 | 0.09 | 0.04 | 0.04 | 0.04 |
| Total Assets | 0.56 | 0.67 | 0.49 | 0.61 | 0.26 | 0.41 | 0.27 |
| Accounts Payable | 0.01 | 0.01 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 |
| Total Current Liabilities | 0.08 | 0.07 | 0.07 | 0.09 | 0.06 | 0.03 | 0.03 |
| Total Non-current Liabilities* | 0.03 | 0.03 | 0.04 | 0.04 | 0.03 | 0.03 | 0.03 |
| Total Liabilities | 0.11 | 0.10 | 0.10 | 0.13 | 0.09 | 0.06 | 0.06 |
| Retained Earnings | (1.14) | (0.99) | (0.81) | (0.70) | (0.76) | (0.56) | (0.47) |
| Total Stockholder Equity | 0.45 | 0.57 | 0.38 | 0.49 | 0.17 | 0.35 | (0.44) |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2
2026 | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 | Q2
2024 |
|---|
| Total Revenue | 1.66 | 1.74 | 1.93 | 2.07 | 2.67 | 17.39 | -- | -- | -- |
| Research & Development | 85.34 | 81.54 | 82.79 | 97.84 | 108.76 | 96.62 | 87.20 | 87.82 | 48.57 |
| Selling, General & Admin | 23.36 | 18.61 | 15.59 | 19.52 | 34.45 | 22.30 | 11.42 | 10.58 | 7.58 |
| Total Operating Expenses | 150.52 | 100.15 | 98.37 | 117.36 | 143.21 | 118.92 | 98.62 | 98.40 | 56.14 |
| Operating Income | (148.85) | (98.41) | (96.44) | (115.29) | (140.54) | (101.53) | (98.62) | (98.40) | (56.14) |
| Pretax Income | (143.98) | -- | (92.93) | (110.75) | 50.76 | -- | -- | -- | -- |
| Tax Provision | (1.76) | -- | 0.00 | 0.00 | (8.56) | -- | -- | -- | -- |
| Net Income | (142.22) | (93.05) | (92.93) | (110.75) | 59.32 | (98.96) | (94.76) | (93.12) | (56.51) |
| Basic EPS | (1.11) | (0.74) | (0.76) | (1.06) | 0.78 | (1.82) | (0.23) | (1.73) | (23.10) |
| Diluted EPS | (1.11) | (0.74) | (0.75) | (1.06) | 0.77 | (1.82) | (0.23) | (1.73) | (23.10) |
Cash Flow Statement
(in millions USD)| Metric | Q2
2026 | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 | Q2
2024 |
|---|
| Operating Cash Flow | (81.50) | (87.08) | (71.91) | (110.91) | (106.35) | (80.35) | (74.76) | (83.77) | (96.55) |
| Capital Expenditures | 0.24 | 0.16 | 0.00 | 0.00 | 0.62 | 0.04 | 0.37 | 0.78 | 0.59 |
| Free Cash Flow* | (81.74) | (87.25) | (71.91) | (110.91) | (106.97) | (80.39) | (75.13) | (84.54) | (97.13) |
| Investing Cash Flow | 68.69 | (285.69) | 95.01 | 24.04 | 129.40 | 39.43 | 30.95 | (93.19) | (51.55) |
| Financing Cash Flow | 12.63 | 346.99 | 1.32 | 0.00 | 0.75 | 129.15 | 0.01 | 235.15 | 257.21 |
* Derived from reported values